Sydney Welt
19Patents
11h-index
42Co-inventors
72Inventor score
Filing activity: Mar 18, 1991 → Feb 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6342587B1 | A33 antigen specific immunoglobulin products and uses thereof | Chemistry; Metallurgy | 73 | Expired |
| US6310185A | Recombinant human anti-Lewis Y antibodies | Chemistry; Metallurgy | 58 | Expired |
| US5712369A | Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein | Chemistry; Metallurgy | 48 | Expired |
| US5160723A | Method of imaging colorectal carcinoma lesion and composition for use therein | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5851526A | Methods of treating colon cancer utilizing tumor-specific antibodies | Chemistry; Metallurgy | 24 | Expired |
| US5874060A | Recombinant human anti-Lewis Y antibodies | Chemistry; Metallurgy | 19 | Expired |
| US5431897A | Method of imaging colorectal carcinoma lesion and composition for use therein | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6652853B2 | Method for treating cancer using A33 specific antibodies and chemotherapeutic agents | Chemistry; Metallurgy | 17 | Expired |
| US6291235A | Isolated nucleic acid which encodes protein which binds to A33 antibody | Chemistry; Metallurgy | 16 | Expired |
| US6190640A | Method for treating neoplasia using humanized antibodies which bind to antigen A33 | Chemistry; Metallurgy | 16 | Expired |
| US5958412A | Methods of treating colon cancer utilizing tumor-specific antibodies | Chemistry; Metallurgy | 11 | Expired |
| US5643550A | Method of treating colorectal carcinoma lesion and composition for use therein | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6346249B1 | Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products | Chemistry; Metallurgy | 6 | Expired |
| US6518415B1 | Recombinant human anti-Lewis Y antibodies | Chemistry; Metallurgy | 4 | Expired |
| US5795961A | Recombinant human anti-Lewis b antibodies | Chemistry; Metallurgy | 3 | Expired |
| US6025481A | Isolated nucleic acid molecules which encode human anti-Lewis b antibodies | Chemistry; Metallurgy | 1 | Expired |
| US9926381B2 | Antibodies targeting B-cell receptor complex membrane bound IGM and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US5565356A | Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines | Human Necessities | 1 | Expired |
| US10227419B2 | Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.